Francis Medical Inc.
Privately held medical device company developing a convective water‑vapor thermal ablation platform and associated transurethral devices for focal treatment of urologic cancers (prostate, kidney, bladder). Core activities include device R&D, multicenter clinical studies (early feasibility to pivotal), regulatory interactions with the U.S. FDA, and capital raises to support clinical development and commercialization. Leadership includes experienced clinical investigators and former regulatory officials supporting clinical and regulatory strategy.
Industries
N/A
Products
Water‑vapor ablation system (transurethral device)
A medical device platform that converts sterile water to vapor and delivers stored thermal energy via a transurethral catheter to ablate targeted urologic tissues.
Water‑vapor ablation system (transurethral device)
A medical device platform that converts sterile water to vapor and delivers stored thermal energy via a transurethral catheter to ablate targeted urologic tissues.
Services
Pivotal and feasibility clinical study execution
Sponsor‑led multicenter clinical studies including site initiation, enrollment, endpoint definition and follow‑up for device safety and efficacy.
Pivotal and feasibility clinical study execution
Sponsor‑led multicenter clinical studies including site initiation, enrollment, endpoint definition and follow‑up for device safety and efficacy.
Expertise Areas
- Clinical trial management for medical devices
- Minimally invasive urologic device development
- Regulatory strategy and FDA interactions (IDE, Breakthrough Device, 510(k) planning)
- Thermal ablation therapies and convective energy delivery
Key Technologies
- Water‑vapor thermal ablation
- Convective thermal energy delivery
- Transurethral minimally invasive delivery
- Focal ablation techniques for urologic cancers